End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
2.82 EGP | 0.00% |
|
+8.05% | -10.19% |
05-19 | Ibnsina Pharma Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
03-03 | Ibnsina Pharma Reports Earnings Results for the Full Year Ended December 31, 2023 | CI |
Business Summary
Number of employees: 5,500
Sales per Business
EGP in Million | 2022 | Weight | 2023 | Weight | Delta |
---|---|---|---|---|---|
Medical and Semi-medical Products
100.0
%
| 22,264 | 100.0 % | 33,949 | 100.0 % | +52.48% |
Sales per region
EGP in Million | 2022 | Weight | 2023 | Weight | Delta |
---|---|---|---|---|---|
Egypt
100.0
%
| 22,264 | 100.0 % | 33,949 | 100.0 % | +52.48% |
Managers
Managers | Title | Age | Since |
---|---|---|---|
Chief Executive Officer | - | 00-12-17 | |
Chief Executive Officer | - | 00-12-17 | |
Momen Gomaa
DFI | Director of Finance/CFO | - | - |
Chief Tech/Sci/R&D Officer | - | - | |
Director/Board Member | - | - | |
Investor Relations Contact | - | 17-10-31 | |
Corporate Officer/Principal | - | - | |
Sales & Marketing | - | - | |
Ahmed Refaat
HRO | Human Resources Officer | - | 12-12-31 |
Members of the board
Members of the board | Title | Age | Since |
---|---|---|---|
Director/Board Member | - | - | |
Chief Executive Officer | - | 00-12-17 | |
Chief Executive Officer | - | 00-12-17 | |
Director/Board Member | - | - | |
Director/Board Member | - | - | |
Director/Board Member | - | - | |
Director/Board Member | - | - | |
Chairman | - | - | |
Director/Board Member | - | - | |
Director/Board Member | - | - |
Share class
Vote | Quantity | Free-Float | Company-owned shares | Total Float | |
---|---|---|---|---|---|
Stock A | 1 | 1,008,000,000 | 618,896,741 ( 61.40 %) | 0 | 61.40 % |
Company contact information
![address Ibnsina Pharma(ISPH)](https://cdn.zonebourse.com/static/address/40443057.png)
Sector
![Consensus](/images/consensus_flch.gif)
EPS Revisions
Annual profits - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
-10.19% | 59.16M | |
-40.02% | 13.51B | |
-44.76% | 9.23B | |
-23.82% | 6.9B | |
-6.57% | 6.05B | |
+83.43% | 4.87B | |
-4.09% | 4.55B | |
+2.24% | 4.34B | |
-20.22% | 4.44B | |
-18.49% | 2.59B |
- Stock Market
- Equities
- ISPH Stock
- Company Ibnsina Pharma